B Cell Lymphoma
Commentary
Cancer Treatment 101: A Primer for Non-Oncologists
Doctor explains why he thinks time of diagnosis is the best time for molecular testing of a new malignant tumor.
Feature
When Childhood Cancer Survivors Face Sexual Challenges
The disruptions caused by cancer and its treatment can interfere with normal physiological and psychological development, leading to issues with...
News
FDA Approves Axatilimab for Chronic GVHD
For children and adults with graft versus host disease, a first-in-class monoclonal antibody axatilimab has received FDA approval.
Feature
Immunotherapy May Be Overused in Dying Patients With Cancer
“There are patients who are getting immunotherapy who shouldn’t,” according to a surgical oncologist from Yale.
From the Journals
Ancient Viruses in Our DNA Hold Clues to Cancer Treatment
Targeting remnants of a virus in our DNA could lead to more effective cancer treatment with fewer side effects.
Feature
Greater Transparency of Oncologists’ Pharma Relationships Needed
Reducing industry payments to hematologists and oncologists could benefit patients, say experts.
From the Journals
Should Cancer Trial Eligibility Become More Inclusive?
A new study highlights the potential benefits of broadening eligibility criteria for clinical trials.
From the Journals
Weight Loss Drugs Cut Cancer Risk in Diabetes Patients
Researchers examine electronic health records of patients who had type 2 diabetes, no prior diagnosis of obesity-related cancers, and had been...
From the Journals
Urticaria Linked to Higher Cancer Risk, Study Finds
Researchers compare the incident cancer risk between patients with urticaria and the general population using data from Danish healthcare...
Feature
Time Warp: Fax Machines Still Common in Oncology Practice. Why?
Oncologists are among the many specialists across the country at the mercy of telecopiers.
Feature
Cancer Drug Shortages Continue in the US, Survey Finds
Not having enough of a significant spectrum of generic chemotherapies and supportive care medications is an ongoing issue, NCCN surveys suggest....